E
Energenesis Biomedical Co Ltd
TWSE:6657
Energenesis Biomedical Co Ltd
TWSE:6657
Price:
45.7
TWD
-4.09%
Market Closed
Market Cap:
NT$4.1B
Cash Flow Statement
Cash Flow Statement
Energenesis Biomedical Co Ltd
Energenesis Biomedical Co Ltd
Currency: TWD
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(105)
|
(125)
|
(150)
|
(151)
|
(129)
|
(117)
|
(120)
|
(167)
|
(266)
|
(322)
|
(318)
|
(363)
|
(260)
|
(247)
|
(199)
|
(244)
|
(231)
|
(285)
|
(284)
|
(244)
|
|
| Depreciation & Amortization |
16
|
17
|
18
|
19
|
20
|
21
|
23
|
24
|
24
|
30
|
24
|
30
|
24
|
24
|
23
|
23
|
23
|
22
|
22
|
22
|
|
| Stock-Based Compensation |
9
|
0
|
11
|
0
|
7
|
0
|
5
|
0
|
11
|
3
|
6
|
6
|
10
|
10
|
11
|
14
|
15
|
20
|
21
|
23
|
|
| Other Non-Cash Items |
7
|
9
|
9
|
7
|
4
|
1
|
3
|
7
|
7
|
9
|
10
|
9
|
5
|
2
|
(3)
|
(0)
|
3
|
4
|
5
|
6
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
|
| Cash Interest Paid |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(4)
|
1
|
2
|
1
|
7
|
7
|
(3)
|
42
|
1
|
(3)
|
(20)
|
(40)
|
7
|
(12)
|
(36)
|
(10)
|
25
|
22
|
10
|
10
|
|
| Cash from Operating Activities |
(85)
N/A
|
(98)
-15%
|
(121)
-24%
|
(125)
-3%
|
(99)
+21%
|
(88)
+11%
|
(97)
-10%
|
(93)
+4%
|
(233)
-150%
|
(286)
-23%
|
(304)
-6%
|
(365)
-20%
|
(225)
+38%
|
(233)
-4%
|
(215)
+8%
|
(231)
-8%
|
(181)
+22%
|
(236)
-31%
|
(247)
-5%
|
(205)
+17%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(3)
|
(3)
|
(2)
|
(1)
|
(3)
|
(8)
|
(9)
|
(9)
|
(7)
|
0
|
(0)
|
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
|
| Other Items |
(235)
|
238
|
(242)
|
(421)
|
62
|
52
|
(107)
|
(13)
|
182
|
0
|
(128)
|
(59)
|
(58)
|
52
|
165
|
115
|
194
|
(198)
|
(90)
|
120
|
|
| Cash from Investing Activities |
(237)
N/A
|
235
N/A
|
(244)
N/A
|
(422)
-73%
|
59
N/A
|
44
-26%
|
(116)
N/A
|
(22)
+81%
|
175
N/A
|
0
N/A
|
(128)
N/A
|
(60)
+54%
|
(59)
+1%
|
52
N/A
|
163
+216%
|
114
-30%
|
193
+69%
|
(199)
N/A
|
(90)
+55%
|
119
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
293
|
247
|
473
|
260
|
9
|
10
|
295
|
294
|
5
|
0
|
449
|
450
|
447
|
454
|
9
|
12
|
151
|
576
|
576
|
574
|
|
| Net Issuance of Debt |
0
|
(1)
|
(37)
|
(37)
|
(4)
|
(6)
|
(7)
|
(6)
|
(7)
|
(8)
|
(7)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
293
N/A
|
246
-16%
|
437
+77%
|
223
-49%
|
5
-98%
|
4
-26%
|
288
+8 105%
|
288
0%
|
(2)
N/A
|
(3)
-94%
|
443
N/A
|
442
0%
|
440
0%
|
448
+2%
|
3
-99%
|
5
+86%
|
145
+2 861%
|
570
+292%
|
570
+0%
|
569
0%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
(29)
N/A
|
383
N/A
|
71
-81%
|
(324)
N/A
|
(35)
+89%
|
(41)
-17%
|
75
N/A
|
173
+130%
|
(59)
N/A
|
(114)
-92%
|
10
N/A
|
18
+74%
|
156
+781%
|
266
+70%
|
(49)
N/A
|
(112)
-127%
|
158
N/A
|
135
-14%
|
233
+72%
|
482
+107%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(88)
N/A
|
(101)
-15%
|
(123)
-22%
|
(126)
-2%
|
(102)
+19%
|
(96)
+5%
|
(106)
-10%
|
(102)
+4%
|
(239)
-134%
|
(286)
-19%
|
(304)
-7%
|
(366)
-20%
|
(226)
+38%
|
(233)
-3%
|
(216)
+7%
|
(232)
-7%
|
(181)
+22%
|
(237)
-31%
|
(248)
-5%
|
(207)
+16%
|
|
Switch to:
Switch to:
See Also
Discover More
